Flucytosine Capsules, USP are indicated only in the treatment of serious infections caused by susceptible strains of Candida and/or Cryptococcus.
![Flucytosine Capsules, USP](/sites/default/files/2018-09/Flucytosine-Capsules-All-Strength.jpg)
-
Compare toAncobon®*
Capsule fill: Corn starch, lactose monohydrate and talc.
The imprinting ink for both the 250 mg and 500 mg capsules contain black iron oxide.
The 250 mg capsule shell contains FD&C Yellow No.6, FD&C Green No. 3, D&C Yellow No. 10, titanium dioxide, sodium lauryl sulfate and gelatin.
The 500 mg capsule shell contains iron oxide yellow, iron oxide black, titanium dioxide, carboxymethylcellulose, sodium lauryl sulfate and gelatin.
![Flucytosine Capsules, USP](/sites/default/files/2018-09/Flucytosine-Capsules-All-Strength.jpg)
Flucytosine Capsules, USP (250 mg)
-
Package size30ct
-
Strength250 mg
-
NDC Code42794-0009-08
![Flucytosine Capsules, USP (250 mg)](/sites/default/files/2018-09/Flucytosine-Capsules-250-mg.jpg)
Flucytosine Capsules, USP (500 mg)
-
Package size30 ct
-
Strength500 mg
-
NDC Code42794-0010-08
![Flucytosine Capsules, USP (500 mg)](/sites/default/files/2018-09/Flucytosine-Capsules-500-mg.jpg)